Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 7, 2019; 25(45): 6634-6652
Published online Dec 7, 2019. doi: 10.3748/wjg.v25.i45.6634
Published online Dec 7, 2019. doi: 10.3748/wjg.v25.i45.6634
Primer | Sense | Antisense |
IL-10 | GCTCCTAGAGCTGCGGACT | TGTTGTCCAGCTGGTCCTTT |
TGF-β1 | CTGGATACCAACTACTGCTTCAG | TTGGTTGTAGAGGGCAAGGACCT |
TNF-α | ACGGCATGGATCTCAAAGAC | TTGGTTGTAGAGGGCAAGGACCT |
IL-6 | CCGGAGAGGAGACTTCACAG | CATTTCCACGATTTCCCAGA |
IL-1β | GCTGCTTCCAAACCTTTGAC | AGCTTCTCCACAGCCACAAT |
iNOS | CACCTTGGAGTTCACCCAGT | ACCACTCGTACTTGGGATGC |
Arg-1 | CTCCAAGCCAAAGTCCTTAGAG | AGGAGCTATCATTAGGGACATC |
β-actin | TGGAATCCTGTGGCATCCATGAAAC | TAAAACGCAGCTCAGTAACAGTCCG |
- Citation: Xu YW, Xing RX, Zhang WH, Li L, Wu Y, Hu J, Wang C, Luo QL, Shen JL, Chen X. Toxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages. World J Gastroenterol 2019; 25(45): 6634-6652
- URL: https://www.wjgnet.com/1007-9327/full/v25/i45/6634.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i45.6634